查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1736503

全球牲畜疫苗市場規模，依疫苗類型、目標動物種類、給藥方式、最終用戶、區域範圍及預測

Global Farm Animal Vaccine Market Size By Type Of Vaccine, By Target Animal Species, By Administration Method, By End-User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格
簡介目錄

牲畜疫苗的市場規模及預測

2024 年牲畜疫苗市場規模價值 95 億美元，預計到 2032 年將達到 166.3 億美元，2026 年至 2032 年的複合年成長率為 7.25%。

推動全球牲畜疫苗市場的因素

牲畜疫苗的市場驅動力可能受到多種因素的影響，其中包括：

動物性蛋白質需求不斷成長：隨著世界人口的成長，對肉類和乳製品的需求也隨之增加。這增加了對健康牲畜的需求，也增加了對疫苗接種的需求，以防止可能降低牲畜生產力的疾病。

牲畜疾病傳播：口蹄疫、禽流感、豬隻繁殖與呼吸綜合症（PRRS）等疾病會為畜牧業帶來巨大的經濟損失。疫苗接種在預防和控制這些疾病方面發揮著至關重要的作用，因此對牲畜疫苗的需求不斷增加。

政府措施和立法：為了遏制動物疾病的傳播，政府和監管機構經常頒布計畫和立法，包括疫苗宣傳活動，從而產生對牲畜疫苗的持續需求。

技術發展：生物技術和疫苗研究的進步帶來了更優質、更安全的疫苗接種。這些發展正在激發市場創造力，促進市場擴張。

增加對動物健康的投資：由於對支持動物保健的基礎設施的投資增加以及對動物健康和福利重要性的認知不斷提高，獸醫疫苗市場正在擴大。

貿易全球化：隨著貿易的擴大，疾病的國際傳播可能性也隨之增加。因此，疫苗宣傳活動對於阻止疾病傳入和傳播到新地區變得更加重要。

通用感染疾病是指可從動物傳播給人類的感染疾病，且正變得越來越普遍。獸醫疫苗的需求源於這樣一個事實：為動物接種疫苗不僅可以保護它們免受某些疾病的侵害，還能降低它們傳播給人類的可能性。

轉向預防性醫療保健：畜牧業的一個趨勢是，農民越來越注重疾病預防而不是治療，這將促進疫苗接種計劃的實施，並增加農業動物疫苗的市場。

集約化養殖模式日益普及：像集中飼養模式（CAFO）這樣的集約化養殖模式，由於牲畜飼養空間狹小，增加了疾病爆發的風險。在這種環境下，疫苗接種對於阻止疾病傳播至關重要，這增加了對牲畜疫苗的需求。

限制全球牲畜疫苗市場的因素

牲畜疫苗市場可能面臨多種限制和挑戰，其中包括：

監管挑戰：監管挑戰：疫苗核准程序漫長而嚴格，這可能會延遲市場採用和成長。

開發成本高：開發牲畜疫苗相關的研發成本會限制市場參與企業並推高疫苗價格。

知識有限：在某些地區，市場成長可能會受到農民的阻礙，因為他們不了解給牲畜接種疫苗的好處，或對其有效性持懷疑態度。

基礎設施挑戰：疫苗分發、管理和儲存基礎設施不足可能會阻礙發展，尤其是在新興國家。

細分市場：大量小型生產者可能導致牲畜疫苗市場細分，從而給價格帶來上行壓力並限制創新。

疾病管制技術：有效的疾病控制技術，例如使用抗生素和生物安全措施，可以大幅減少某些農業經營中對疫苗接種的需求。

來自傳統藥物的競爭：在某些市場，疫苗可能面臨來自預防和治療疾病的傳統手段（如抗生素和草藥）的競爭。

經濟因素：經濟因素：經濟衰退和商品價格波動可能會影響農民購買疫苗和其他預防措施的能力。

對過度使用的擔憂：過度使用疫苗會導致對疫苗有抗藥性的疾病菌株，並對牲畜健康產生不利影響。

抵制變革：農民和農業社區可能會抵制採用新技術和新做法，例如疫苗接種，這可能會阻礙市場擴張。

目錄

第1章全球牲畜疫苗市場簡介

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章全球牲畜疫苗市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

5. 全球牲畜疫苗市場（依疫苗類型）

  • 活病毒疫苗
  • 去活化疫苗
  • 次單位疫苗
  • DNA疫苗

6. 全球獸用疫苗市場（依動物種類）

  • 牛
  • 豬
  • 家禽
  • 綿羊和山羊

7. 全球牲畜疫苗市場（依給藥方式）

  • 注射疫苗
  • 口服疫苗
  • 鼻用疫苗

8. 全球牲畜疫苗市場（依最終用戶）

  • 獸醫醫院和診所
  • 畜牧生產者
  • 獸醫診斷實驗室
  • 動物保健公司

9. 全球牲畜疫苗市場（按地區）

  • 概述
  • 北美洲
    • 美國
  • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他
    • 拉丁美洲
    • 中東和非洲

第10章全球獸用疫苗市場的競爭格局

  • 概述
  • 各公司市場排名
  • 重點發展策略

第11章 公司簡介

  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • WINSUN
  • Ringpu Biology
  • Ceva
  • CAHIC
  • HVRI
  • Bio-Labs
  • Yebio

第12章 附錄

  • 相關調查
簡介目錄
Product Code: 37126

Farm Animal Vaccine Market Size And Forecast

Farm Animal Vaccine Market size was valued at USD 9.5 USD Billion in 2024 and is projected to reach USD 16.63 USD Billion by 2032, growing at a CAGR of 7.25% during the forecast period 2026-2032.

Global Farm Animal Vaccine Market Drivers

The market drivers for the Farm Animal Vaccine Market can be influenced by various factors. These may include:

Growing Need for Animal Protein: The demand for meat and dairy products rises in tandem with the growth of the world's population. Because of this, there is a greater requirement for healthy farm animals, which raises the need for vaccinations to stave off illnesses that could lower livestock productivity.

Animal illness prevalence: The cattle business can suffer large financial losses as a result of diseases including foot-and-mouth disease, avian influenza, and porcine reproductive and respiratory syndrome (PRRS). The need for vaccines for agricultural animals is fueled by the critical role immunizations play in both preventing and controlling these diseases.

Government Initiatives and laws: To stop the spread of animal diseases, governments and regulatory agencies frequently put programs and laws into place. This includes immunization campaigns, which generate a consistent need for vaccines for farm animals.

Technological developments: Better and safer vaccinations for farm animals have been made possible by developments in biotechnology and vaccine research. These developments stimulate the market's creativity and aid in its expansion.

Increasing Investments in Animal Health: The market for farm animal vaccines is expanding as a result of rising investments in the infrastructure supporting animal healthcare as well as growing awareness of the significance of animal health and welfare.

Trade Globalization: As trade grows, there is a greater chance that diseases will spread internationally. As a result, immunization campaigns are more important to stop the introduction and spread of illnesses to new areas.

Zoonotic diseases are infections that can spread from animals to people and are becoming more common. The need for farm animal vaccines is fueled by the fact that immunizing animals against certain illnesses not only protects them but also lowers the possibility of human infection.

Transition to Preventive Healthcare: Farmers are putting more of an emphasis on preventing illnesses than treating them as a result of a growing tendency in animal husbandry. This promotes vaccination programs' uptake and expands the market for vaccines intended for agricultural animals.

Growing Adoption of Intensive Farming Practices: Because animals are kept in close quarters, intensive farming methods-like concentrated animal feeding operations (CAFOs)-increase the danger of disease outbreaks. Because vaccinations are crucial in stopping the spread of disease in these kinds of settings, there is an increased need for farm animal vaccines.

Global Farm Animal Vaccine Market Restraints

Several factors can act as restraints or challenges for the Farm Animal Vaccine Market. These may include:

Regulatory Difficulties: The lengthy and rigorous regulatory licensing procedures for vaccines might cause delays in the introduction or growth of the market.

High Development expenditures: Research and development expenditures associated with developing vaccines for farm animals might restrict market participants and drive up vaccine pricing.

Limited Knowledge: The growth of the market may be hampered in some areas by farmers who are unaware of the advantages of vaccinations for their animals or who have doubts about their effectiveness.

Infrastructure Challenges: Inadequate infrastructure for the distribution, administration, and storage of vaccines might obstruct market expansion in some areas, particularly in developing nations.

Fragmented Market: Due to the large number of small-scale producers, the market for farm animal vaccines may be fragmented, which could put pressure on prices and restrict innovation.

Disease Control techniques: In certain farming operations, the apparent need for vaccinations may be lessened by effective disease control techniques such the use of antibiotics and biosecurity measures.

Competition from Traditional Medicines: In certain markets, vaccines may face competition from traditional means of illness prevention and treatment, such as antibiotics or herbal medicines.

Economic Factors: Farmers' capacity to spend in vaccines and other preventive measures may be impacted by downturns in the economy or changes in commodity prices.

Concerns regarding Overuse: There may be worries that using vaccines excessively could result in the emergence of disease strains resistant to vaccinations or have a negative impact on the health of animals.

Resistance to Change: Some farmers or farming communities may be resistant to implementing new technologies or practices, such as vaccinations, which could impede the expansion of the market.

Global Farm Animal Vaccine Market Segmentation Analysis

The Global Farm Animal Vaccine Market is Segmented on the basis of Type of Vaccine, Target Animal Species, Administration Method, End-User, and Geography.

Farm Animal Vaccine Market, By Type of Vaccine

  • Live Attenuated Vaccines: Vaccines containing weakened forms of the pathogen that stimulate an immune response in animals without causing disease, providing long-lasting immunity with a single dose.
  • Inactivated Vaccines: Vaccines containing killed or inactivated pathogens, which require multiple doses or booster shots to induce immunity but are safer for use in pregnant animals and young animals with developing immune systems.
  • Subunit Vaccines: Vaccines composed of specific antigens or proteins from the pathogen, offering targeted immune responses with reduced risk of adverse reactions compared to whole-cell vaccines.
  • DNA Vaccines: Vaccines that deliver genetic material encoding antigenic proteins into animal cells, stimulating both humoral and cellular immune responses for long-term protection against pathogens.

Farm Animal Vaccine Market, By Target Animal Species

  • Cattle: Vaccines developed specifically for cattle to prevent diseases such as bovine respiratory disease (BRD), bovine viral diarrhea (BVD), infectious bovine rhinotracheitis (IBR), and clostridial infections.
  • Pigs: Vaccines designed for pigs to protect against diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, porcine circovirus-associated diseases (PCVAD), and classical swine fever.
  • Poultry: Vaccines formulated for poultry species including chickens, turkeys, and ducks to prevent diseases such as Newcastle disease, infectious bronchitis, avian influenza, Marek's disease, and infectious bursal disease.
  • Sheep and Goats: Vaccines tailored for sheep and goats to control diseases such as foot-and-mouth disease (FMD), enterotoxemia, clostridial infections, and contagious ecthyma (orf).

Farm Animal Vaccine Market, By Administration Method

  • Injectable Vaccines: Vaccines administered through injection into muscle tissue or under the skin, providing targeted delivery and reliable immune responses.
  • Oral Vaccines: Vaccines administered orally through feed or drinking water, offering ease of administration and potential for mass vaccination of large animal populations.
  • Intranasal Vaccines: Vaccines delivered through the nasal passages, stimulating mucosal immunity and providing protection against respiratory pathogens in farm animals.

Farm Animal Vaccine Market, By End-User

  • Veterinary Hospitals and Clinics: Facilities providing veterinary services and healthcare to farm animals, including vaccination programs, preventive care, and treatment of infectious diseases.
  • Livestock Producers: Farmers, ranchers, and livestock producers responsible for managing the health and well-being of farm animals, including implementing vaccination protocols and disease prevention strategies.
  • Veterinary Diagnostic Laboratories: Laboratories conducting diagnostic tests, serological assays, and vaccine efficacy studies to monitor disease prevalence, assess vaccine effectiveness, and guide vaccination strategies.
  • Animal Health Companies: Manufacturers and suppliers of farm animal vaccines, veterinary pharmaceuticals, and biological products, offering a range of vaccine formulations and solutions for disease prevention and control.

Farm Animal Vaccine Market, By Geographic

  • North America: Market dynamics and trends specific to the farm animal vaccine industry in North American regions, including the United States, Canada, and Mexico.
  • Europe: Market factors and regulatory influences shaping the farm animal vaccine market across European countries such as the UK, Germany, France, and Italy.
  • Asia Pacific: Growth opportunities and market expansion strategies relevant to farm animal vaccines in countries like China, India, Japan, and Australia.
  • Latin America: Market trends and consumer preferences impacting the farm animal vaccine market in Latin American regions like Brazil, Argentina, and Chile.
  • Middle East and Africa: Factors driving demand for farm animal vaccines in regions like the Middle East and Africa, including increasing livestock production, disease outbreaks, and government initiatives for animal health.

Key Players

  • The major players in the Farm Animal Vaccine Market are:
  • Elanco
  • Virbac
  • Vetoquinol S.A.

4Hester Biosciences Limited

  • Phibro Animal Health Corporation
  • HIPRA

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FARM ANIMAL VACCINE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL FARM ANIMAL VACCINE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL FARM ANIMAL VACCINE MARKET, BY TYPE OF VACCINE

  • 5.1 Live Attenuated Vaccines
  • 5.2 Inactivated Vaccines
  • 5.3 Subunit Vaccines
  • 5.4 DNA Vaccines

6 GLOBAL FARM ANIMAL VACCINE MARKET, BY TARGET ANIMAL SPECIES

  • 6.1 Cattle
  • 6.2 Pigs
  • 6.3 Poultry
  • 6.4 Sheep and Goats

7 GLOBAL FARM ANIMAL VACCINE MARKET, BY ADMINISTRATION METHOD

  • 7.1 Injectable Vaccines
  • 7.2 Oral Vaccines
  • 7.3 Intranasal Vaccines

8 GLOBAL FARM ANIMAL VACCINE MARKET, BY END-USER

  • 8.1 Veterinary Hospitals and Clinics
  • 8.2 Livestock Producers
  • 8.3 Veterinary Diagnostic Laboratories
  • 8.4 Animal Health Companies

9 GLOBAL FARM ANIMAL VACCINE MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
  • 92.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East And Africa

10 GLOBAL FARM ANIMAL VACCINE MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Ranking
  • 10.3 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 Boehringer Ingelheim
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 Merck
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Zoetis
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 WINSUN
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Ringpu Biology
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Ceva
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.11 CAHIC
    • 11.11.1 Overview
    • 11.11.2 Financial Performance
    • 11.11.3 Product Outlook
    • 11.11.4 Key Developments
  • 11.8 HVRI
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.11 Bio-Labs
    • 11.11.1 Overview
    • 11.11.2 Financial Performance
    • 11.11.3 Product Outlook
    • 11.11.4 Key Developments
  • 11.10 Yebio
    • 11.10.1 Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Outlook
    • 11.10.4 Key Developments

12 Appendix

  • 10.1 Related Research